CymitQuimica logo

CAS 1173699-31-4

:

Ordenar por

Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Encontrado 6 productos.
  • Ref: IN-DA000E62

    1mg
    58,00€
    10mg
    168,00€
    25mg
    205,00€
    50mg
    291,00€
    100mg
    501,00€
  • AMG-337

    CAS:
    AMG-337
    Pureza:≥98%
    Peso molecular:463.46g/mol

    Ref: 54-BUP08211

    5mg
    116,00€
    10mg
    180,00€
    25mg
    285,00€
    50mg
    499,00€
    100mg
    719,00€
    200mg
    996,00€
  • (R)-6-(1-(8-Fluoro-6-(1-Methyl-1H-Pyrazol-4-Yl)-[1,2,4]Triazolo[4,3-A]Pyridin-3-Yl)Ethyl)-3-(2-Methoxyethoxy)-1,6-Naphthyridin-5(6H)-One

    CAS:
    (R)-6-(1-(8-Fluoro-6-(1-Methyl-1H-Pyrazol-4-Yl)-[1,2,4]Triazolo[4,3-A]Pyridin-3-Yl)Ethyl)-3-(2-Methoxyethoxy)-1,6-Naphthyridin-5(6H)-One
    Pureza:98+%
    Peso molecular:463.46g/mol

    Ref: 54-PC108757

    1mg
    A consultar
    10mg
    A consultar
    25mg
    A consultar
    50mg
    A consultar
    100mg
    637,00€
  • AMG-337

    CAS:
    AMG-337 is an effective and highly specific ATP-competitive MET kinase inhibitor. In enzymatic assays, AMG-337 inhibits MET kinase activity (IC50: < 5 nM).
    Fórmula:C23H22FN7O3
    Pureza:99.26% - 99.9%
    Forma y color:Solid
    Peso molecular:463.46
  • AMG 337

    Producto controlado
    CAS:
    <p>Applications AMG 337 is a potent and selective inhibitor of mesencymal epethelial transition factor (MET factor) which has been implicated in several cancers.<br>References Boezio, A. et al.: J. Med. Chem., 59, 2326 (2016);<br></p>
    Fórmula:C23H22FN7O3
    Forma y color:Neat
    Peso molecular:463.46

    Ref: TR-A576575

    5mg
    179,00€
    10mg
    298,00€
    25mg
    627,00€
  • AMG 337

    CAS:
    <p>AMG 337 is a small molecule inhibitor, which is derived from synthetic chemical processes, with a mode of action involving the selective inhibition of the c-Met receptor tyrosine kinase. The c-Met receptor, also known as hepatocyte growth factor receptor, plays a critical role in various cellular processes such as proliferation, survival, and motility. Dysregulation of c-Met signaling is implicated in several types of cancers, making it a significant therapeutic target.</p>
    Fórmula:C23H22FN7O3
    Pureza:Min. 95%
    Peso molecular:463.46 g/mol

    Ref: 3D-YWB69931

    50mg
    1.306,00€